Sign in
CompletedNo phase

Competitive Revision for CLARO: Collaboration Leading to Addiction Treatment and Recovery From Other Stresses

Key facts

Who runs it
RAND
Where
Albuquerque, Belen, Edgewood, Los Angeles, Los Lunas, and Santa Monica, United StatesSee the 12 sites
Trial code
Status
Completed
People taking part
68 people enrolled
Started
31 Aug 2022
Ended
12 Jun 2024
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Collaborative care Plus
Record updated
9 August 2024

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • 18 and older
  • Receiving primary care at one of the participating clinical sites
  • Has OUD and one or more specific co-occurring behavioral health disorders (depression and PTSD)

Who cannot take part

  • Receiving both MOUD and psychotropic medication from a provider outside of the primary care health system at which the patient is enrolled
  • Not receiving primary care at one of the participating clinical sites
  • Under 18
  • Does not speak English or Spanish
  • Unable to consent

Where in United States

  • First Choice - Alameda Medical CenterAlbuquerque, United States
  • First Choice Community Healthcare - Alamosa Medical CenterAlbuquerque, United States
  • First Choice Community Healthcare - North Valley Medical CenterAlbuquerque, United States
  • First Choice Community Healthcare - South Broadway Medical CenterAlbuquerque, United States
  • First Choice Community Healthcare - South Valley Medical/Dental CenterAlbuquerque, United States
  • University of New Mexico Family Health Clinic, North ValleyAlbuquerque, United States
  • University of New Mexico Family Health Clinic, Southeast HeightsAlbuquerque, United States
  • First Choice Community Healthcare - Belen Medical CenterBelen, United States
  • First Choice Community Healthcare - Edgewood Medical/Dental CenterEdgewood, United States
  • Hubert Humphrey Comprehensive Health CenterLos Angeles, United States
  • First Choice Community Healthcare - Los Lunas Medical/Dental CenterLos Lunas, United States
  • Providence Saint John's Health CenterSanta Monica, United States

About the trial

What the trial wants to find out

The purpose of this study is to develop and then test an enhanced version of the parent study's collaborative care intervention for co-occurring disorders (CC-COD) to reduce the risk of suicide and overdose among individuals with opioid use disorder (OUD) in combination with PTSD/depression. The parent study is CLARO, Collaboration Leading to Addiction Treatment and Recovery from Other Stresses (NCT04559893).

The 2 groups in the trial

  • Collaborative Care PlusTreatment being tested

    Intervention is administered to patients in this arm. Care to be delivered via collaborative care. The supplement intervention adds family involvement in care and Caring Contacts, a suicide prevention method.

  • ControlNo study treatment, for comparison

    Patients in this arm will receive enhanced usual care.

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Competitive Revision for Improving Access and Treatment for Co-occurring Opioid Use Disorders and Mental Illness
Publications
Record updated
9 August 2024